The U.S. Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones. The FDA said Wednesday it approved the drug, Xofigo from Bayer Pharmaceuticals, for men whose cancer has grown into bone tumors even after receiving medication or surgery to lower testosterone.
Atlas Venture has entered into Corporate Strategic Partnership (CSP) agreements with both Amgen...
The World Health Organization says a yellow fever booster vaccination given 10...
Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has...
Johnson & Johnson's DePuy orthopedics business plans to stop selling a couple of hip replacement systems not widely used by doctors. DePuy will discontinue both its Ultamet Metal-on-Metal Articulation and Complete Ceramic-on-Metal Acetabular systems worldwide at the end of August. It made the...
The range of the Cape Europe ‘Optima TS®’ Rapid Transfer Port includes the industry standard 190, 270 and 350 sizes of 'alpha' ports and ‘beta’ containers. The system has a four way mechanical lock and is 100% interchangeable with the Getinge/La Calhene DPTE® RTP.
The new Shodex HPLC Column catalog which features scores of application chromatograms, charts and diagrams that describe a very wide selection of separation modes such as reversed phase, hydrophilic interaction, normal phase, ligand exchange, ion exclusion, ion chromatography, size exclusion, ion exchange, hydrophobic interaction, affinity and chiral separations.
The new separation conveyors are designed to provide extremely high magnetic fields, which enable removal of lightly magnetic tramp metal fines. High-intensity magnetic fields also separate work-hardened 300 series stainless steel from the product stream.
NBE 3-A, USDA, FDA and BISSC-compliant bulk bag filling systems are engineered, fabricated, and constructed to speed inspections, simplify integration, and ensure qualification for start-up into processing and packaging operations.
This liquid filling system was designed to fill, insert a pump, crimp, and cap containers at rates greater than 50 cpm. The difficulty of accurately placing a dip tube/pump into a small neck opening and crimping the closure onto a glass bottle is the challenge that is solved with this system.
Impax Laboratories Inc. said Friday it is now selling a generic version of the migraine drug Zomig. Impax is now selling a low-cost generic version of Zomig tablets and orally disintegrating Zomig tablets in two strengths. Zomig, or zolmitriptan, is available in tablet and nasal spray form and as...
FreezeBooster™ is a patented technique to enable controlled nucleation during the freezing step of the freeze drying cycle. A combination of the most sophisticated laboratory freeze dryer with the most powerful PC/PLC control system to enable One-Run Protocol development.
CD-3 is a new tool in the Food and Drug Administration’s fight against counterfeit products. CD-3 is a low-cost, portable tool that uses light to detect counterfeit products. CD-3 can be deployed anywhere and is helping the FDA protect consumers.
Scientists have used cloning technology to transform human skin cells into embryonic stem cells, an experiment that may revive the controversy over human cloning. These cloned cells can be used to create fresh tissue in the lab to repair damage done by various ailments.
Changes in the marketplace have forced the public health community to wrestle with the idea that some tobacco products may pose less of a health risk than others, the new head of the Food and Drug Administration's tobacco control efforts told an industry group on Thursday.
Halozyme posted results from an early-stage trial that included its drug PEGPH20 as a treatment for pancreatic cancer. The regimen included PEGPH20 and the cancer drug Gemzar. Halozyme said PEGPH20 may make tumors more vulnerable to treatment by depleting their defenses and changing their metabolism.
Galapagos NV and AbbVie announced today an extension of their GLPG0634 clinical development collaboration to include Crohn's disease. Galapagos will fund and complete a Phase 2 program in Crohn's disease, which is designed to facilitate rapid progression into Phase 3.
Oramed Pharmaceuticals Inc. a developer of oral drug delivery systems, announced today that the United States Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug application(IND) for ORMD-0801, its oral insulin capsule.
High-shear mixers that can be quickly and cost-effectively customized to meet unique processing challenges. Mixing processes vary from each application but having a flexible bowl configuration offers greater efficiency and permits working volumes from 30 – 90% of full capacity.